Fiji rolls out Pfizer vaccination for children

A team from the Fiji Pharmaceutical and Biomedical Team began dispatching the vaccine around Viti Levu yesterday in order for all vaccination centres to be ready for launch today.

Minister for Health Doctor Ifereimi Waqainabete while receiving the Pfizer vaccine from the New Zealand High Commission reiterated the need for children to get vaccinated.

Permanent Secretary Doctor James Fong said this will also protect children who have not yet been vaccinated and are below that eligible age group.

Pfizer vaccine rollout next week for youth in Tonga, but unvaccinated over-18s too slow

The plan is to start rolling out the Pfizer vaccine after its arrival on 20 October, in schools around Tonga. Young people with disabilities will also be vaccinated.

Town Officers and church groups in each suburb or area will assist health teams to also reach out to families with young children who are not registered at schools.

To date, out of 63,128 people aged 18 years and over, 50,001 people have received their first dose of the Astra Zeneca vaccines, while 30,953 have received their second doses.

Pfizer becomes first Covid vaccine to gain full FDA approval

The vaccine had initially been given emergency use authorisation. Its two jabs, three weeks apart, are now fully approved for those aged 16 and older.

The approval is expected to set off more vaccine mandates by employers and organisations across the country.

It comes amid lingering vaccine hesitancy among many Americans.

In a statement, the FDA said its review for approval included data from approximately 44,000 people. The vaccine, which will now be marketed as Comirnaty, was found to be 91% effective in preventing Covid disease.

Pfizer says it could be leader in cancer with many new drugs

A decade ago, the world's second-biggest drugmaker by revenue wasn't even a player in cancer medicine. Instead, it was known for erectile dysfunction treatment Viagra and blockbuster cholesterol fighter Lipitor.

New York-based Pfizer Inc. then chose to make cancer one of its core research areas, pitting it against cancer powerhouses including Novartis AG, Roche Holding AG, Bristol-Myers Squibb Co. and Merck & Co.